DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) rose 4.03% to $165.61 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.30% to 7,720.39 and Dow Jones Industrial Average falling 0.25% to 52,342.56.
This was the stock's fourth consecutive day of gains.
Gilead Sciences Inc. hit a new 52-week high, surpassing its previous peak of $160.83, which the company achieved on October 28th.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 1.53% to $275.20, Pfizer Inc. $(PFE)$ rose 1.70% to $29.95, and Abbott Laboratories $(ABT)$ rose 1.88% to $104.57.
Trading volume (8.3 M) eclipsed its 50-day average volume of 5.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 29, 2026.
Comments